Back
MeiraGTx Holdings PLC 10K Form
Sell
49
MGTX
MeiraGTx Holdings PLC
Last Price:
4.98
Seasonality Move:
4.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-06 | 10Q | MGTX/MeiraGTx Holdings PLC Quarterly |
| 2020-05-07 | 10Q | MGTX/MeiraGTx Holdings PLC Quarterly |
| 2020-03-11 | 10K | MGTX/MeiraGTx Holdings PLC Annual |
| 2019-11-07 | 10Q | MGTX/MeiraGTx Holdings PLC Quarterly |
| 2019-08-07 | 10Q | MGTX/MeiraGTx Holdings PLC Quarterly |
| 2019-05-14 | 10Q | MGTX/MeiraGTx Holdings PLC Quarterly |
Receive MGTX News And Ratings
See the #1 stock for the next 7 days that we like better than MGTX
MGTX Financial Statistics
Sales & Book Value
| Annual Sales: | $14.02M |
|---|---|
| Cash Flow: | $-17.58M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.17 |
| Price / Book: | 2.33 |
Profitability
| EPS (TTM): | -1.47000 |
|---|---|
| Net Income (TTM): | $-84.03M |
| Gross Margin: | -- |
| Return on Equity: | -74.82% |
| Return on Assets: | -27.81% |
MeiraGTx Holdings PLC Earnings Forecast
Key MeiraGTx Holdings PLC Financial Ratios
- The Research & Development expenses have been 740.42% of Revenue.
- The Interest Expense is -15.76% of Operating Income.
- The Net Earning history of MGTX is -599.46% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 3 years.
MeiraGTx Holdings PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MGTX |
| CUSIP: | G59665 |
| Website: | meiragtx.com |
Debt
| Debt-to-Equity Ratio: | 0.52 |
|---|---|
| Current Ratio: | 2.38 |
| Quick Ratio: | 2.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 17.65 |
MGTX Technical Analysis vs Fundamental Analysis
Sell
49
MeiraGTx Holdings PLC (MGTX)
is a Sell
Is MeiraGTx Holdings PLC a Buy or a Sell?
-
MeiraGTx Holdings PLC stock is rated a Sell
The current MeiraGTx Holdings PLC [MGTX] share price is $5.00. The Score for MGTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.